-
-
-
-
-
-
-
U.K. approves ARS Pharmaceuticals' needle-free epinephrine nasal spray
-
-
-
-
-
-
-
Dexcom (DXCM) Removes Certain Dexcom G6, G7, ONE, and ONE+ Receivers Due to Speaker Malfunction
-
-
-
-
-
-
-
Asia Broadband receives phase 2 equipment for Mexico facility
-
-
-
-
-
-
-
SK bioscience submits application for adjuvanted flu vaccine trial
-
-
-
-
-
-
-
Quince Therapeutics completes enrollment in phase 3 ataxia trial
-
-
-
-
-
-
-
Neurocrine shares registry data showing CAH treatment challenges
-
-
-
-
-
-
-
ZYUS Life Sciences appoints hematologist-oncologist as chief medical officer
-
71,224 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.